**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| Not available |Di-iso-propylnaphthalene | 50-60.0 | unlisted |
|----------------|--------------------------------------|----------|-----------|
| Not available |1,4-Di(-2-methylstyryl)benzene | 0-1.0 | unlisted |
|----------------|--------------------------------------|----------|-----------|
| Not available |Nonylphenol 9 mole ethoxylate | 20-25.0 | unlisted |
|----------------|--------------------------------------|----------|-----------|
| Not available |Nonylphenol 5 mole ethoxylate | 0-5.0 | unlisted |
|----------------|--------------------------------------|----------|-----------|
| Not available |bis(2-hydroxypropylether) | 0-5.0 | unlisted |
|----------------|--------------------------------------|----------|-----------|
| Not available |Lauroyl sarcosine acid form | 0-5.0 | unlisted |
|----------------|--------------------------------------|----------|-----------|
| 92-71-7 |2,5-Diphenyloxazole | 0-1.0 | 202-181-3 |
|----------------|--------------------------------------|----------|-----------|
| 111-42-2 |Diethanolamine | 0-1.0 | 203-868-0 |
|----------------|--------------------------------------|----------|-----------|
| 112-34-5 |Diethylene glycol monobutyl ether | 10-15.0 | 203-961-6 |
|----------------|--------------------------------------|----------|-----------|
| 16940-66-2 |Sodium borohydride | 0-1.0 | 241-004-4 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: XN
Risk Phrases: 38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to skin.
Potential Health Effects
Eye:
May cause severe eye irritation.
Skin:
May cause severe skin irritation and burns.
Ingestion:
May cause irritation of the digestive tract. May be harmful if
swallowed.
Inhalation:
May cause severe respiratory tract irritation.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately. Do NOT allow victim to rub eyes or keep eyes closed.
Skin:
Get medical aid immediately. Flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Discard contaminated clothing in a manner which limits further
exposure.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Combustible material; may burn but does not ignite
readily.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid
contact with eyes, skin, and clothing. Keep container tightly closed.
Keep away from heat, sparks and flame. Avoid ingestion and
inhalation.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of
ignition. Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate general or local exhaust ventilation to keep airborne
concentrations below the permissible exposure limits.
Exposure Limits
CAS# 0-00-0:
CAS# 0-00-1:
CAS# 0-00-2:
CAS# 0-00-3:
CAS# 0-00-4:
CAS# 0-00-5:
CAS# 92-71-7:
CAS# 111-42-2:
Belgium - TWA: 0.46 ppm VLE; 2 mg/m3 VLE
France - VME: 3 ppm VME; 15 mg/m3 VME
Germany: 15 mg/m3 TWA (inhalable fraction)
Germany: Skin absorber
Malaysia: 0.46 ppm TWA; 2 mg/m3 TWA
Netherlands: 0.46 ppm MAC; 2 mg/m3 MAC
Russia: 5 mg/m3 TWA
Spain: 0.46 ppm VLA-ED; 2 mg/m3 VLA-ED
CAS# 112-34-5:
Germany: 100 mg/m3 TWA
Netherlands: 9 ppm MAC; 50 mg/m3 MAC
Spain: 100 mg/m3 VLA-ED
CAS# 16940-66-2:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: colorless
Odor: perceptible odor
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: > 140 deg C (> 284.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 0.982
Molecular Formula:
Molecular Weight:
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable.
Conditions to Avoid:
Incompatible materials, ignition sources.
Incompatibilities with Other Materials:
Oxidizing agents, ruthenium salts, alkalis, anhydrous acids, dimethyl
formamide, sulfuric acid, palladium, diborane + bis(2-methoxyethyl)
ether, polyglycols, dimethylacetamide, metal salts.
Hazardous Decomposition Products:
Not known.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 0-00-0 unlisted.
CAS# 0-00-1 unlisted.
CAS# 0-00-2 unlisted.
CAS# 0-00-3 unlisted.
CAS# 0-00-4 unlisted.
CAS# 0-00-5 unlisted.
CAS# 92-71-7: RP6825000
CAS# 111-42-2: KL2975000
CAS# 112-34-5: KJ9100000
CAS# 16940-66-2: ED3325000
LD50/LC50:
Not available.
Not available.
Not available.
Not available.
Not available.
Not available.
Not available.
CAS# 111-42-2: Dermal, guinea pig: LD50 = 11900 uL/kg; Draize test,
rabbit, eye: 5500 mg Severe; Draize test, rabbit, eye: 750 ug/24H
Severe; Draize test, rabbit, skin: 500 mg/24H Mild; Oral, mouse:
LD50 = 3300 mg/kg; Oral, rabbit: LD50 = 2200 mg/kg; Oral, rat: LD50 =
620 uL/kg; Skin, rabbit: LD50 = 7640 uL/kg.
CAS# 112-34-5: Draize test, rabbit, eye: 20 mg Severe; Draize test,
rabbit, eye: 20 mg/24H Moderate; Oral, mouse: LD50 = 2400 mg/kg;
Oral, mouse: LD50 = 6050 mg/kg; Oral, rabbit: LD50 = 2200 mg/kg;
Oral, rat: LD50 = 5660 mg/kg; Oral, rat: LD50 = 4500 mg/kg; Skin,
rabbit: LD50 = 2700 mg/kg.
CAS# 16940-66-2: Inhalation, rat: LC50 = 36 mg/m3; Oral, mouse: LD50
= 50 mg/kg; Oral, rabbit: LD50 = 50 mg/kg; Oral, rat: LD50 = 162
mg/kg; Skin, rabbit: LD50 = 230 mg/kg.
CAS# 112-34-5 Oral rat LD50= 1746-10502
Carcinogenicity:
Di-iso-propylnaphthalene -
Not listed by ACGIH, IARC, or NTP.
1,4-Di(-2-methylstyryl)benzene -
Not listed by ACGIH, IARC, or NTP.
Nonylphenol 9 mole ethoxylate -
Not listed by ACGIH, IARC, or NTP.
Nonylphenol 5 mole ethoxylate -
Not listed by ACGIH, IARC, or NTP.
bis(2-hydroxypropylether) -
Not listed by ACGIH, IARC, or NTP.
Lauroyl sarcosine acid form -
Not listed by ACGIH, IARC, or NTP.
2,5-Diphenyloxazole -
Not listed by ACGIH, IARC, or NTP.
Diethanolamine -
Not listed by ACGIH, IARC, or NTP.
Diethylene glycol monobutyl ether -
Not listed by ACGIH, IARC, or NTP.
Sodium borohydride -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Products which are considered hazardous for supply are classified as Special
Waste and the disposal of such chemicals is covered by regulations which may
vary according to location. Contact a specialist disposal company or the local
waste regulator for advice. Empty containers must be decontaminated before
returning for recycling.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
No information available.
IMO
No information available.
RID/ADR
No information available.
USA RQ: CAS# 111-42-2: 100 lb final RQ; 45.4 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 38 Irritating to skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 28B After contact with skin, wash immediately with
plenty of water and soap.
WGK (Water Danger/Protection)
CAS# 0-00-0: No information available.
CAS# 0-00-1: No information available.
CAS# 0-00-2: No information available.
CAS# 0-00-3: No information available.
CAS# 0-00-4: No information available.
CAS# 0-00-5: No information available.
CAS# 92-71-7: No information available.
CAS# 111-42-2: 1
CAS# 112-34-5: 1
CAS# 16940-66-2: 2
Canada
CAS# 92-71-7 is listed on Canada's DSL List.
CAS# 111-42-2 is listed on Canada's DSL List.
CAS# 112-34-5 is listed on Canada's DSL List.
CAS# 16940-66-2 is listed on Canada's DSL List.
CAS# 0-00-0 is not listed on Canada's Ingredient Disclosure List.
CAS# 0-00-1 is not listed on Canada's Ingredient Disclosure List.
CAS# 0-00-2 is not listed on Canada's Ingredient Disclosure List.
CAS# 0-00-3 is not listed on Canada's Ingredient Disclosure List.
CAS# 0-00-4 is not listed on Canada's Ingredient Disclosure List.
CAS# 0-00-5 is not listed on Canada's Ingredient Disclosure List.
CAS# 92-71-7 is not listed on Canada's Ingredient Disclosure List.
CAS# 111-42-2 is listed on Canada's Ingredient Disclosure List.
CAS# 112-34-5 is listed on Canada's Ingredient Disclosure List.
CAS# 16940-66-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 0-00-0 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 0-00-1 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 0-00-2 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 0-00-3 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 0-00-4 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 0-00-5 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 92-71-7 is listed on the TSCA inventory.
CAS# 111-42-2 is listed on the TSCA inventory.
CAS# 112-34-5 is listed on the TSCA inventory.
CAS# 16940-66-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 10/02/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|